27.10.2021 – 08:01
Lyfegen HealthTech AG
BASEL, Switzerland, Jan. 23 / PRNewswire /
Lyfegen announces that the Swiss health insurance company Sympany uses the Lyfegen platform for complex pricing models. Sympany uses the Lyfegen platform to implement and efficiently manage all price models in the list of specialties (SL) and Art. 71 KVV (Art. 71). Sympany is gaining efficiency and transparency in the management of pricing models with the Lyfegen platform. This offers many pricing models, including pay-for-performance, combination therapy and indication-based models.
The Lyfegen software platform digitizes all SL and Art. 71 pricing models and automates the administration and execution of these agreements between health insurers and pharmaceutical companies. It is fully based on machine learning. With the Lyfegen platform, Sympany is also creating the basis for sustainably handling the increasing number of value-based healthcare contracts for drugs. These new pricing models allow health insurers to better manage their financial risk by only paying for drugs that work for patients.
“The Lyfegen platform supports Sympany in implementing complex pricing models efficiently, securely and transparently. We are delighted that we can expand our pioneering role in the health insurance industry by working with Lyfegen. This is a further step for Sympany, our customers To enable the best possible access to therapies, “says Nico Camuto, Head of Services at Sympany, about the use of the Lyfegen platform.
Girisha Fernando, CEO of Lyfegen, explains: “We are very proud to support Sympany in strengthening their focus on value creation, efficiency and transparency in the face of the growing complexity of pricing models. It is clear that the trend is more and more complex Pay-for-performance arrangements are all about. Ultimately, our goal is to help patients get their much-needed treatments while helping health insurers better manage risks and costs. “
The Lyfegen platform aims to make it easier for patients to access innovative medicines and treatments by enabling innovative drug price agreements. The platform collects and analyzes data for pricing in real time and enables health insurers and pharmaceutical companies to obtain relevant information on the benefits of the drugs and the associated financial planning.
Sympany is the refreshingly different insurance that offers tailor-made protection and unbureaucratic help. Sympany is active in health and accident insurance for individuals and companies as well as in property and liability insurance and is headquartered in Basel. The group of companies under the umbrella of Sympany Holding AG comprises the insurance companies Vivao Sympany AG, Moove Sympany AG, Kolping Krankenkasse AG and Sympany Insurance AG, as well as the service company Sympany Services AG.
In 2020, profit amounted to CHF 68.8 million, of which Sympany allocated CHF 27.5 million to the surplus fund for the benefit of its policyholders. The total premium volume amounted to CHF 1,058 million. With 575 employees, the company looks after around 257,100 private customers, including around 204,500 people with basic insurance under the KVG. In the corporate customer business, Sympany offers loss of earnings and accident insurance.
More about Sympany: https://www.sympany.ch
Lyfegen is an independent, global software analytics company that provides a value and results-based contract platform for health insurers, pharmaceutical companies, medtech companies and hospitals around the world. The secure Lyfegen platform identifies and operationalizes value-based payment models cost-effectively and on a large scale using a variety of real data and machine learning. Lyfegen’s patent-pending platform enables health insurers and hospitals to implement and scale value-based healthcare, improving access to treatment, patient health outcomes and affordability.
Based in the United States and Switzerland, Lyfegen was founded by a team with decades of experience in the healthcare, pharmaceuticals and technology sectors to facilitate the transition from volume-based, paid healthcare to value-based healthcare.
More about Lyfegen: https://www.lyfegen.com
Weitere Links: https://www.lyfegen.com Linkedin: https://www.linkedin.com/company/lyfegenhealth
Contact for the press: [email protected]
Contact for investors: [email protected]
+41 79 105 93 47
Original content by: Lyfegen HealthTech AG, transmitted by news aktuell